ADAMTS13 and thrombotic thrombocytopenic purpura: We identified two CD46‐mutated patients (patients 3 and 4), presenting with a relapsing/remitting TMA clinically indistinguishable from TTP, with normal renal function and ADAMTS‐13 levels.